Zug, Switzerland – 13th May 2025 – Partners4Access (P4A), a global leader in market access for orphan drugs and advanced therapies, is excited to host the P4A Access Summit 2025: JCA & Market Expansion Unlocked in Zug, Switzerland, on Tuesday, 13th May 2025.
This exclusive in-person event will bring together senior industry professionals, and stakeholders in rare disease, cell & gene therapy, and market access to address some of the most pressing challenges in European drug commercialization.
With the Joint Clinical Assessment (JCA) set to reshape market access, participants will gain practical expertise on navigating the evolving framework, including PICO selection and the EU Pharmaceutical Strategy. The event will equip attendees with the tools and strategies needed to successfully launch orphan drugs, oncology products and advanced therapies across Europe.
Why Attend?
✔ Master the JCA framework – understand the mechanics and how to prepare for upcoming changes
✔ Unpack EU regulatory hurdles – tackle launch conditionality for orphan drugs and ATMPs
✔ Engage with senior industry leaders – connect with peers in an intimate, interactive setting
✔ Hands-on workshop – led by market access specialists to help future-proof your product strategy
Agenda at a Glance
📌 Morning Session:
JCA Workshop – Mechanics, working within principles, and preparing your PICOs
📌 Afternoon Session:
Global Expansion – Strategies for ensuring market success
📌 Networking & Drinks Reception
Event Details & Registration
📍 Location: Zug, Switzerland
💰 Fees: CHF 295 (Early Bird – book by 30th March) | CHF 500 (Standard – after 30th March)
📅 Limited spaces available – secure your spot today!
For more details and to register, visit https://partners4access.com/insights/p4a-access-summit-2025/ or contact us at grack@partners4access.com
